data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
ChromaDex
(NASDAQ:CDXC)
$1.67
-0.08[-4.57%]
At close: Jun 30
$1.67
00
After Hours: 4:34PM EDT
Day High/Low1.66 - 1.8
52 Week High/Low1.51 - 10.54
Open / Close1.74 / 1.67
Float / Outstanding60.2M / 68.3M
Vol / Avg.490.5K / 632.4K
Mkt Cap114.1M
P/E-
50d Avg. Price1.86
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float60.2M

ChromaDex (NASDAQ:CDXC), Quotes and News Summary

ChromaDex (NASDAQ: CDXC)

Day High/Low1.66 - 1.8
52 Week High/Low1.51 - 10.54
Open / Close1.74 / 1.67
Float / Outstanding60.2M / 68.3M
Vol / Avg.490.5K / 632.4K
Mkt Cap114.1M
P/E-
50d Avg. Price1.86
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float60.2M
Benzinga - 6 days ago
Benzinga - Jun 10, 2022, 6:35AM
Benzinga - Jun 7, 2022, 6:23AM
Benzinga - Jun 2, 2022, 6:37AM
Benzinga - May 20, 2022, 10:02AM
Benzinga - May 19, 2022, 4:34PM
Benzinga - May 13, 2022, 10:05AM
Benzinga - May 12, 2022, 4:32PM
Benzinga - May 12, 2022, 4:31PM
Benzinga - Apr 18, 2022, 6:16AM
Benzinga - Apr 6, 2022, 6:34AM
Benzinga - Mar 16, 2022, 6:35AM
Benzinga - Mar 10, 2022, 11:35AM
Benzinga - Mar 9, 2022, 4:03PM
Benzinga - Mar 8, 2022, 8:09AM
Benzinga - Feb 9, 2022, 6:35AM
Benzinga - Jan 25, 2022, 6:35AM
Benzinga - Jan 20, 2022, 11:22AM
Benzinga - Jan 20, 2022, 10:39AM
load more
Sector: Health Care.Industry: Life Sciences Tools & Services
ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS-0.090-0.110 -0.0200
REV17.230M17.259M29.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ChromaDex Questions & Answers

Q
How do I buy ChromaDex (CDXC) stock?
A

You can purchase shares of ChromaDex (NASDAQ: CDXC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ChromaDex's (CDXC) competitors?
Q
What is the target price for ChromaDex (CDXC) stock?
A

The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on Tuesday, June 7, 2022. The analyst firm set a price target for 7.00 expecting CDXC to rise to within 12 months (a possible 319.16% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ChromaDex (CDXC)?
A

The stock price for ChromaDex (NASDAQ: CDXC) is $1.67 last updated June 30, 2022, 8:00 PM UTC.

Q
Does ChromaDex (CDXC) pay a dividend?
A

There are no upcoming dividends for ChromaDex.

Q
When is ChromaDex (NASDAQ:CDXC) reporting earnings?
A

ChromaDex’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is ChromaDex (CDXC) going to split?
A

There is no upcoming split for ChromaDex.

Q
What sector and industry does ChromaDex (CDXC) operate in?
A

ChromaDex is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.